分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

CRISPR-iPAS: a novel dCAS13-based method for alternative polyadenylation interference

Tian Shuye, Zhang Bin, He Yuhao, Sun Zhiyuan, Li Jun, Li Yisheng, Yi Hongyang, Zhao Yan, Zou Xudong, Li Yunfei, Cui Huanhuan, Fang Liang, Gao Xin, Hu Yuhui, Chen Wei

Journal:NUCLEIC ACIDS RESEARCH

IF:19.16

DOI:10.1093/nar/gkac108

PMID:35191504

Published:2022-02-22

research field:

Abstract

Alternative polyadenylation (APA) plays an important role in gene regulation. With the recent application of novel sequencing technology in APA profiling, an ever-increasing number of APA genes/sites have been identified. However, the phenotypic relevance of most of these APA isoforms remains elusive, which is largely due to the lack of a convenient genetics tool for APA interference. To address this issue, herein, an efficient method is developed based on the CRISPR-dCas13 system, termed as CRISPR-iPAS. Out of eight different dCas13 proteins, Porphyromonas gulae (Pgu) dCas13b, is identified as the most effective one in blocking the usage of the polyadenylation site (PAS). With guide RNAs targeting at core regulatory elements, dPguCas13b enabled APA regulation of endogenous genes with different APA types, including tandem 3′UTR, alternative terminal exon, as well as intronic PAS. Finally, we demonstrated that the proposed APA perturbation tool could be used to investigate the functional relevance of APA isoforms.

本文使用的Yeasen产品

相关产品
购物车
客服
转染试用